No COPD | New COPD | Confirmed COPD | Former COPD | |
Subjects n | 236 | 84 | 50 | 16 |
Baseline | ||||
Any pulmonary medication | 41 (17.4) | 24 (28.6) | 40 (80.0) | 13 (81.3) |
Inhaled medication | 24 (10.2) | 21 (25.0) | 39 (78.0) | 13 (81.3) |
β-agonists | 6 (2.5) | 7 (8.3) | 8 (16) | 5 (31.1) |
Anticholinergics | 11 (4.6) | 5 (6.0) | 30 (60.0) | 7 (37.8) |
Corticosteroids | 6 (2.5) | 5 (6.0) | 7 (14.0) | 3 (18.8) |
β-agonist+corticosteroids | 8 (3.4) | 14 (16.7) | 22 (44.0) | 8 (50.0) |
Other pulmonary medication# | 18 (7.6) | 3 (3.6) | 7 (14.0) | 2 (12.5) |
After 6 months of follow-up | ||||
Any pulmonary medication | 31 (13.1) | 32 (38.1) | 39 (78.0) | 12 (75.0) |
Inhaled medication | 23 (9.8) | 30 (35.7) | 39 (78.0) | 12 (75.0) |
β-agonists | 6 (2.5) | 5 (6.0) | 14 (28.0) | 4 (25.0) |
Anticholinergics | 9 (3.8) | 11 (13.1) | 30 (60.0) | 7 (37.8) |
Corticosteroids | 5 (2.1) | 8 (9.5) | 8 (16.0) | 2 (12.5) |
β-agonist+corticosteroids | 8 (3.4) | 15 (17.9) | 19 (38.0) | 7 (37.8) |
Other pulmonary medication# | 8 (3.4) | 2 (2.4) | 4 (8.0) | 0 (0.0) |
Data are presented as n (%) unless otherwise stated. No COPD: no diagnosis of COPD and no COPD according to panel; new COPD: no diagnosis of COPD but COPD according to panel; confirmed COPD: diagnosis of COPD and COPD according to panel; former COPD: diagnosis of COPD but no COPD according to panel. #: oral corticosteroids (70%), mucolytics (16%), theophylline (7%) and antileukotrienes (7%).